¿En que me puede ayudar la terapia?Ayuda a recuperar las capacidades funcionales y cognitivas
Estimula y Regula el sistema inmunológico Aumenta la función cerebral y neuronal Estimula las neuronas dormidas Favorece la micro y macro circulación Reduce la inflamación Ayuda a que las células y tejidos sanen con mayor eficacia 
|
OXIGENOTERAPIA EN ENFERMEDADES AUTOINMUNESA presiones mayores de lo normal, el cuerpo puede incorporar más oxígeno a las células sanguíneas, el plasma sanguíneo, el líquido cefalorraquídeo y otros fluidos corporales. El aumento de la absorción de oxígeno experimentado durante TOHB aumenta la circulación de células madre en un 800 % y mejora la capacidad del cuerpo para curarse a sí mismo. Los efectos conocidos de TOHB incluyen la reducción de la inflamación, la curación de infecciones y la reparación de tejidos dañados. El aumento de los niveles de oxígeno en los tejidos donde se han reducido debido a una enfermedad o lesión estimula el crecimiento de los vasos sanguíneos, reduce la inflamación y apoya el sistema inmunológico. Estos efectos proporcionan un alivio sintomático significativo y retrasan o reducen la progresión de la enfermedad.
LA OXIGENACIÓN HIPERBÁRICA en CONDICIONES CronicasMiles de personas sufren de condiciones crónicas y desórdenes neurológicos, en muchos casos, afectando y deteriorando la vida de cada individuo. La terapia de oxígeno hiperbárico puede mejorar sus condiciones ayudando a contrarrestar el deterioro, produciendo un cambio de vida positivo.
Muchos trastornos neurológicos y crónicos son simplemente debido a una disminución de oxígeno en el cerebro o diferentes tejidos. Debido a que el cerebro es el órgano en el cuerpo que utiliza la mayor parte del oxígeno, muchos trastornos asociados con deterioro cognitivo se puede revertir o prevenir con el Oxigenacion Hiperbarica. Actualmente hay más de 80 enfermedades tratadas con éxito con esta terapia en todo el mundo. |
Quien se puede beneficiar de el Oxigeno 100%
|
Alzheimer y Demencia temprana
Parkinson Fibromialgia Esclerosis Múltiple (grado kurtzke 5 o menos) Artritis Reumatoide Derrame Cerebral o Lesión cerebral y sus efectos secundarios (ej. contusiones, golpes o derrames) Lesiones de médula espinal Síndrome de Fatiga Crónica Cualquier síndrome de dolor Esclerodermia Soriasis Eczema Liquen escleroso o plano Dermatitis |
|
Alergias
Problemas del tracto gastrointestinal (ej. crohn, colitis ulcerativa y colon irritable) Trastornos del sueño Estrés Migrañas Arteriosclerosis Insuficiencia venosa y arterial Lesiones de médula espinal Neuropatías periféricas Parálisis de Bell (parálisis de cara) Condiciones del oído (ej. Meniere, tinnitus, sordera súbita) Gastritis Enfermedades de corazón Enfermedad de Lyme |
|
SÍNTOMAS POR FALTA DE OXÍGENO
Debido a que la deficiencia de oxígeno a menudo suele pasar que no es visto como una causa de enfermedad crónica. Algunos de los síntomas que pueden derivarse de la falta de oxígeno son: envejecimiento prematuro, depresión, fatiga, falta de brillo y una sensación general de pesadez. Si el desequilibrio se vuelve crónico, el sistema inmunológico se debilita y las personas se vuelven más susceptibles a que una enfermedad se vuelva crónica.
Con nuestras vidas cada vez más ocupadas, muchos de nosotros nos olvidamos de tomar el tiempo para simplemente reducir nuestra velocidad y oler las rosas. Incluso sin las condiciones mencionadas anteriormente, esta terapia puede ser de gran ayuda para cualquier persona, no sólo para ayudar a cuando las cosas se vuelvan crónicas, si no como mantenimiento de un buen estilo de vida. |
"La enfermedad crónica es una enfermedad de larga duración que puede ser controlada muy bien con la ayuda de la terapia de oxigeno."
|
¿QUE ES UNA ENFERMEDAD CRÓNICA?La enfermedad crónica es una enfermedad de larga duración que puede ser controlada pero no curada. La enfermedad crónica afecta a la población en todo el mundo. Las enfermedades crónicas son la principal causa de muerte y discapacidad en el mundo. Aunque las enfermedades crónicas son uno de los problemas más comunes y costosos de la salud, también se encuentran entre los más prevenibles y la mayoría se puede controlar con eficacia con el uso de varias terapias.
Nutricion y enf. AutoinmuneLos trastornos autoinmunes se ven exacerbados por trastornos en el intestino. También son muy sensibles a los cambios en la dieta. Cuando las personas que padecen enfermedades autoinmunes implementan dietas curativas, se obtienen mejoras (a menudo dramáticas) en la salud física y psicológica.
|
Investigaciones
Role of hyperbaric oxygen therapy in the treatment of bacterial spinal osteomyelitis“Hyperbaric oxygen therapy enabled infection cure in 5 of 6 patients with spinal osteomyelitis complicated by medical comorbidities or the failure of primary therapy. These results show that HBO may be a useful adjunctive therapeutic modality in the treatment of spinal osteomyelitis, particularly when there are medical comorbidities that increase the risk of poor healing. Hyperbaric oxygen therapy may also be beneficial in patients with relapsing primary spinal osteomyelitis after standard therapy has failed.”
The effects of hyperbaric oxygen therapy on oxidative stress, inflammation, and symptoms in children with autism: an open-label pilot study“In this prospective pilot study of children with autism, HBOT at a maximum pressure of 1.5 atm with up to 100% oxygen was safe and well tolerated. HBOT did not appreciably worsen oxidative stress and significantly decreased inflammation as measured by CRP levels. Parental observations support anecdotal accounts of improvement in several domains of autism”
Hyperbaric-Oxygen Treatment of Multiple Sclerosis — A Randomized, Placebo-Controlled, Double-Blind Study“Objective improvement occurred in 12 of 17 patients treated with hyperbaric oxygen and in 1 of 20 patients treated with placebo.”
Early hyperbaric oxygen therapy attenuates disease severity in lupus-prone autoimmune (NZB x NZW) F1 mice.“HBO(2) treatment resulted in increased survival, decreased proteinuria, alterations in lymphocyte-subset redistribution, reduced anti-dsDNA antibody titers, and amelioration of immune-complex deposition in groups A and B. Our data demonstrated that HBO(2) therapy attenuated disease severity in NZB/W F1 mice. HBO(2) treatment may be of use in the clinical treatment of lupus patients and would benefit from further study.”
Hyperbaric oxygen for perianal Crohn’s disease“we undertook a trial of this method in 10 patients with refractory perianal disease. These patients’ perianal Crohn’s disease had not responded to treatment that included local medications, salicylates, corticosteroids, metronidazole, or 6-mercaptopurine were treated. Treatment was administered in a hyperbaric chamber at a pressure of 2.5 atm absolute. Each session lasted 90 min, and each course consisted of 20 daily sessions. Complete healing occurred in 5 patients after one to two courses. In an additional 2, after three courses, 1 patient improved but did not heal, and 2 did not improve. No adverse effects were noted by any of the 10 patients. Follow-up of 18 months did not reveal any recurrence. These preliminary results confirm that HBO therapy is a safe and efficient therapeutic option for perianal Crohn’s disease.”
Improvement of attention span and reaction time with hyperbaric oxygen treatment in patients with toxic injury due to mold exposure
“It is, by now, well established that mold toxins (mycotoxins) can cause significant adverse health effects. In this study, 15 subjects who developed an attention deficit disorder (ADD) and slowing of reaction time at the time of exposure to mold toxins were identified. Deficits in attention span and reaction time were documented not only by taking a careful history, but also by performing a Test of Variables of Attention (TOVA). The TOVA test provides an objective measure of these two variables. It was found that mold-exposed subjects show statistically significant decreases in attention span and significant increases in reaction time to stimuli compared to controls. After ten sessions of hyperbaric oxygen treatment (HBOT), a statistically significant improvement was seen in both measures. This preliminary study suggests promising outcomes in treating mold-exposed patients with hyperbaric oxygen.”
Attenuation of collagen-induced arthritis by hyperbaric oxygen therapy through altering immune balance in favor of regulatory T cells.
“Hyperbaric oxygen (HBO₂) therapy is currently used for the treatment of chronic wounds, radiation-induced soft tissue necrosis, several oxygen-deficiency conditions and decompression sickness. In addition to the current indications, much empirical and experimental data suggest that HBO₂ therapy may benefit autoimmune diseases by suppressing immunity, but the underlying mechanism is not well understood. Therefore, in the present study, we investigated whether HBO₂ prevents the development of collagen-induced arthritis (CIA) in association with alteration of the immune balance between pro-inflammatory Th17 and anti-inflammatory regulatory T cells (Tregs).”
Microcirculation in patients with systemic scleroderma during treatment using hyperbaric oxygenation.
Hyperbaric oxygenation treatment of systemic scleroderma has a favourable effect on microcirculatory changes whose positive dynamics can be demonstrated by conjunctival biomicroscopy. These changes include accelerated blood flow and decrease in the degree of erythrocyte aggregation. The method can be used for the objective assessment and for prognosis of the effectiveness of hyperbaric oxygenation treatment in patients with systemic scleroderma.
The effects of hyperbaric oxygen therapy on oxidative stress, inflammation, and symptoms in children with autism: an open-label pilot study“In this prospective pilot study of children with autism, HBOT at a maximum pressure of 1.5 atm with up to 100% oxygen was safe and well tolerated. HBOT did not appreciably worsen oxidative stress and significantly decreased inflammation as measured by CRP levels. Parental observations support anecdotal accounts of improvement in several domains of autism”
Hyperbaric-Oxygen Treatment of Multiple Sclerosis — A Randomized, Placebo-Controlled, Double-Blind Study“Objective improvement occurred in 12 of 17 patients treated with hyperbaric oxygen and in 1 of 20 patients treated with placebo.”
Early hyperbaric oxygen therapy attenuates disease severity in lupus-prone autoimmune (NZB x NZW) F1 mice.“HBO(2) treatment resulted in increased survival, decreased proteinuria, alterations in lymphocyte-subset redistribution, reduced anti-dsDNA antibody titers, and amelioration of immune-complex deposition in groups A and B. Our data demonstrated that HBO(2) therapy attenuated disease severity in NZB/W F1 mice. HBO(2) treatment may be of use in the clinical treatment of lupus patients and would benefit from further study.”
Hyperbaric oxygen for perianal Crohn’s disease“we undertook a trial of this method in 10 patients with refractory perianal disease. These patients’ perianal Crohn’s disease had not responded to treatment that included local medications, salicylates, corticosteroids, metronidazole, or 6-mercaptopurine were treated. Treatment was administered in a hyperbaric chamber at a pressure of 2.5 atm absolute. Each session lasted 90 min, and each course consisted of 20 daily sessions. Complete healing occurred in 5 patients after one to two courses. In an additional 2, after three courses, 1 patient improved but did not heal, and 2 did not improve. No adverse effects were noted by any of the 10 patients. Follow-up of 18 months did not reveal any recurrence. These preliminary results confirm that HBO therapy is a safe and efficient therapeutic option for perianal Crohn’s disease.”
Improvement of attention span and reaction time with hyperbaric oxygen treatment in patients with toxic injury due to mold exposure
“It is, by now, well established that mold toxins (mycotoxins) can cause significant adverse health effects. In this study, 15 subjects who developed an attention deficit disorder (ADD) and slowing of reaction time at the time of exposure to mold toxins were identified. Deficits in attention span and reaction time were documented not only by taking a careful history, but also by performing a Test of Variables of Attention (TOVA). The TOVA test provides an objective measure of these two variables. It was found that mold-exposed subjects show statistically significant decreases in attention span and significant increases in reaction time to stimuli compared to controls. After ten sessions of hyperbaric oxygen treatment (HBOT), a statistically significant improvement was seen in both measures. This preliminary study suggests promising outcomes in treating mold-exposed patients with hyperbaric oxygen.”
Attenuation of collagen-induced arthritis by hyperbaric oxygen therapy through altering immune balance in favor of regulatory T cells.
“Hyperbaric oxygen (HBO₂) therapy is currently used for the treatment of chronic wounds, radiation-induced soft tissue necrosis, several oxygen-deficiency conditions and decompression sickness. In addition to the current indications, much empirical and experimental data suggest that HBO₂ therapy may benefit autoimmune diseases by suppressing immunity, but the underlying mechanism is not well understood. Therefore, in the present study, we investigated whether HBO₂ prevents the development of collagen-induced arthritis (CIA) in association with alteration of the immune balance between pro-inflammatory Th17 and anti-inflammatory regulatory T cells (Tregs).”
Microcirculation in patients with systemic scleroderma during treatment using hyperbaric oxygenation.
Hyperbaric oxygenation treatment of systemic scleroderma has a favourable effect on microcirculatory changes whose positive dynamics can be demonstrated by conjunctival biomicroscopy. These changes include accelerated blood flow and decrease in the degree of erythrocyte aggregation. The method can be used for the objective assessment and for prognosis of the effectiveness of hyperbaric oxygenation treatment in patients with systemic scleroderma.
